BMPR2 and pulmonary arterial hypertension: Loss of function mutation in BMPR2 occurs in 60–80% of familial cases of PAH patients, but the disease penetrance rate is low [29,30], suggesting that, in addition to the gene mutations, other unidentified genetic, epigenetic, or environmental factors may contribute to the pathogenesis of PAH.